Clinical Trials in San Francisco

Showing 5881-5900 of 12,991 trials

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ACH-0137171 in Participants With Chronic Hepatitis C Infection

NCT00401947

The purpose of this study was to investigate the safety, tolerability, pharmacokinetics (PK), and antiviral activity of multiple doses of ACH-0137171 in participants with chronic hepatitis C virus (HCV) infection.

HCV Infection

Alexion Pharmaceuticals, Inc.30 participantsStarted Nov 2006

Phoenix, Arizona, United States • La Jolla, California, United States • San Francisco, California, United States +6 more locations

COMPLETEDPhase 1< 1 mile

A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)

NCT01920061

This study will evaluate PF-05212384 (gedatolisib) PI3K/mTOR inhibitor)) in combination with either docetaxel, cisplatin or dacomitinib in select advanced solid tumors. The study will assess the safety, pharmacokinetics and pharmacodynamics of these combinations in patients with advanced cancer in order to determine the maximum tolerated dose in each combination. The cisplatin combination expansion portion will evaluate the anti tumor activity of PF 05212384 plus cisplatin in patients with TNBC in 2 separate Arms (Arm 1 and Arm 2).

Neoplasm

Pfizer110 participantsStarted Sep 2013

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Los Angeles, California, United States +26 more locations

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ACH-0137171 in Participants With Chronic Hepatitis C Infection

A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)

Find Trials by Condition in San Francisco

A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis

Lovastatin for the Treatment of Mildly Active Rheumatoid Arthritis

Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

A Comparison Study of LY2140023 and Aripiprazole in Schizophrenia Patients

Voice Biomarkers Predictive of Depression and Anxiety

DELPHI in Subjects at Risk for Stroke and Dementia

Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC)

Determination of Voiding Patterns of Children With Vesicoureteral Reflux

Overcoming Barriers and Obstacles to Adopting Diabetes Devices

MGTA-145 + Plerixafor in the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Multiple Myeloma

MR-Guided Focused Ultrasound in the Treatment of Focal Epilepsy (EP001)

Feasibility Study for GORE® TAG® Thoracic Branch Endoprosthesis to Treat Proximal Descending Thoracic Aortic Aneurysms

Study to Evaluate the Safety and Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED)

Long-Term Safety of ARQ-151 Cream in Adult Subjects With Chronic Plaque Psoriasis

The Safety, Efficacy and Pharmacokinetics of ARQ-151 Cream in Subjects With Chronic Plaque Psoriasis

Registrational Trial to Compare Effectiveness of Two Digital Software Medical Devices as Adjunctive Oncology Treatment

LIFT Home Study of Non-Invasive ARC Therapy for Spinal Cord Injury